---
title: "Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and Asia"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237955221.md"
description: "Huaxia Eye stated during an institutional research that according to the latest strategic layout, the company has also begun its overseas expansion. Considering the recent changes in the international environment, it will focus on acquisition targets primarily in Europe and Asia, including high-quality ophthalmic medical service institutions, and upstream equipment and consumables manufacturers with sustainable R&D capabilities and competitive products. The company is currently recruiting a Director of Overseas Investment and Mergers & Acquisitions"
datetime: "2025-04-29T01:55:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237955221.md)
  - [en](https://longbridge.com/en/news/237955221.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237955221.md)
generator: "portal-rs"
---

# Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and Asia

Huaxia Eye stated during an institutional research that according to the latest strategic layout, the company has also begun its overseas expansion. Considering the recent changes in the international environment, it will focus on acquisition targets primarily in Europe and Asia, including high-quality ophthalmic medical service institutions, and upstream equipment and consumables manufacturers with sustainable R&D capabilities and competitive products. The company is currently recruiting a Director of Overseas Investment and Mergers & Acquisitions

### Related Stocks

- [301267.CN](https://longbridge.com/en/quote/301267.CN.md)

## Related News & Research

- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches](https://longbridge.com/en/news/296914529.md)
- [Helium Evolution financing creates three new 15% shareholders: Maxey, Tough Investments, Howard](https://longbridge.com/en/news/296842566.md)
- [Avanti Helium secures up to US $10 million convertible credit facility with RiverFort Global Opportunities](https://longbridge.com/en/news/296806980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**